TPG asked banks to submit proposals for the potential listing of Pathology Asia in March and was weighing Singapore as an option for the listing venue
SINGAPORE: Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region ahead of a potential initial public offering (IPO) for the unit, according to people with knowledge of the matter.
The buyout firm could sell a 20% stake in Pathology Asia Holdings Pte and is working with advisers on the potential divestment, said the people, who asked not to be identified as the process is private.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
